| ADC | antibody–drug conjugate |
| CTCL | cutaneous T-cell lymphoma |
| DAR | drug to antibody ratio |
| ETBR | endothelin B receptor |
| FcRn | neonatal Fc receptor |
| FDA | food and drug administration |
| Gal-3BP | galectin-3-binding protein |
| gpNMB | glycoprotein-NMB |
| ICI | immune checkpoint inhibitors |
| LRRC15 | leucine-rich repeat containing 15 mAb: monoclonal antibody |
| MCC | Merkel cell carcinoma |
| MF | mycosis fungoides |
| MMAE | monomethyl auristatin E |
| MMAF | monomethyl auristatin F |
| PBD | pyrrolobenzodiazepines |
| PDX | patient-derived xenograft |
| RTK | receptor tyrosine kinase |
| SCC | squamous cell carcinoma |
| SS | Sézary syndrome |
| TF | tissue factor |
| TME | tumor microenvironment |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.